Protocol Improves ABO-Incompatible Transplants Renal and Urology News, NY No cases of hyperacute rejection were reported, and no grafts were lost secondary to AMR. In addition, fewer than 17% of patients experienced a clinical episode of AMR. Elimination of B-cell ablative therapies did not result in an increased incidence ... |
